MA26515A1 - Derives imidazoles d'alkylsulfonamides et d'uree, procede pour leur preparation, compositions pharmaceutiques les contenant, et leur utilisation pour traiter l'incontinence urinaire. - Google Patents

Derives imidazoles d'alkylsulfonamides et d'uree, procede pour leur preparation, compositions pharmaceutiques les contenant, et leur utilisation pour traiter l'incontinence urinaire.

Info

Publication number: MA26515A1
Authority: MA; Morocco
Prior art keywords: alkylsulfonamides; urea; preparation; pharmaceutical compositions; compositions containing
Prior art date: 1997-06-23

Application number

MA25130A

Other languages

English (en)

Inventor

Leo Cournoyer Richard

Francis Keitz Paul

Mitsugu Yasuda Dennis

O'yang Counde

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-23

Filing date

1998-06-22

Publication date

2004-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26515(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-22 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26515A1 publication Critical patent/MA26515A1/fr

Links

RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
206010046543 Urinary incontinence Diseases 0.000 title 1
239000004202 carbamide Substances 0.000 title 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Diabetes (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

MA25130A 1997-06-23 1998-06-22 Derives imidazoles d'alkylsulfonamides et d'uree, procede pour leur preparation, compositions pharmaceutiques les contenant, et leur utilisation pour traiter l'incontinence urinaire. MA26515A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5047997P	1997-06-23	1997-06-23
US7597898P	1998-02-25	1998-02-25

Publications (1)

Publication Number	Publication Date
MA26515A1 true MA26515A1 (fr)	2004-12-20

Family

ID=26728313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25130A MA26515A1 (fr)	1997-06-23	1998-06-22	Derives imidazoles d'alkylsulfonamides et d'uree, procede pour leur preparation, compositions pharmaceutiques les contenant, et leur utilisation pour traiter l'incontinence urinaire.

Country Status (30)

Country	Link
US (2)	US5952362A (fr)
EP (1)	EP0887346B1 (fr)
JP (1)	JP2977536B2 (fr)
KR (1)	KR100608501B1 (fr)
CN (3)	CN1176910C (fr)
AR (1)	AR013005A1 (fr)
AT (1)	ATE380793T1 (fr)
AU (1)	AU713068C (fr)
BR (1)	BR9802201B1 (fr)
CA (3)	CA2430623A1 (fr)
CO (1)	CO4940479A1 (fr)
CZ (1)	CZ197498A3 (fr)
DE (1)	DE69838829T2 (fr)
ES (1)	ES2297870T3 (fr)
HR (1)	HRP980353A2 (fr)
HU (1)	HUP9801357A3 (fr)
ID (1)	ID20463A (fr)
IL (2)	IL124839A (fr)
MA (1)	MA26515A1 (fr)
MY (1)	MY128048A (fr)
NO (1)	NO310868B1 (fr)
NZ (1)	NZ330506A (fr)
PE (1)	PE85999A1 (fr)
PL (1)	PL198053B1 (fr)
RU (1)	RU2218335C2 (fr)
SG (1)	SG72827A1 (fr)
TR (1)	TR199801197A3 (fr)
TW (1)	TW517049B (fr)
UY (1)	UY25057A1 (fr)
YU (1)	YU26498A (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6407132B1 (en) *	1997-07-25	2002-06-18	James Black Foundation Limited	Substituted imidazole derivatives and their use as histamine H3 receptor ligands
DE19824175A1 (de) *	1998-05-29	1999-12-02	Novartis Ag	Amino-azol-Verbindungen
US20030073850A1 (en) *	1998-08-07	2003-04-17	Altenbach Robert J.	4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6503935B1 (en) *	1998-08-07	2003-01-07	Abbott Laboratories	Imidazoles and related compounds as α1A agonists
US6395758B1 (en) *	1998-08-14	2002-05-28	Gpi Nil Holdings, Inc.	Small molecule carbamates or ureas for vision and memory disorders
GB9910110D0 (en) *	1999-04-30	1999-06-30	Glaxo Group Ltd	Chemical compounds
US6323231B1 (en)	2000-02-17	2001-11-27	Abbott Laboratories	Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
US20020183357A1 (en) *	2000-02-17	2002-12-05	Brioni Jorge D.	Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence
AU2001259536A1 (en) *	2000-05-10	2001-11-20	The Cleveland Clinic Foundation	Model systems for neurodegenerative and cardiovascular disorders
WO2002015902A1 (fr) *	2000-08-23	2002-02-28	Merck & Co., Inc.	Procede pour traiter et prevenir l'incontinence urinaire par utilisation d'antagonistes de recepteur ep1 de prostanoide
WO2002038133A2 (fr) *	2000-11-10	2002-05-16	F. Hoffman-La Roche Ag	Compositions hydrolytiquement instables
DE10106214A1 (de) *	2001-02-10	2002-08-14	Boehringer Ingelheim Pharma	Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
US20020169193A1 (en) *	2001-02-10	2002-11-14	Pascale Pouzet	Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
US20040170689A1 (en) *	2001-11-09	2004-09-02	Odink Debra Alida	Stabilized formulations comprising hydrolytically unstable compositions
EP1333028A1 (fr) *	2002-01-31	2003-08-06	Boehringer Ingelheim Pharma GmbH & Co.KG	Dérivés de 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine et lur utilisation pour le traitement de l'incontinence urinaire
US6703409B2 (en)	2002-01-31	2004-03-09	Boehringer Ingelheim Pharma Gmbh & Co Kg	2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
PL373410A1 (en) *	2002-02-01	2005-08-22	F.Hoffman-La Roche Ag	Substituted indoles as alpha-1 agonists
EP1501817A1 (fr) *	2002-04-23	2005-02-02	F. Hoffmann-La Roche Ag	Aralkylsulfonamides d'imidazolinylmethyle
ATE406363T1 (de) *	2003-05-09	2008-09-15	Hoffmann La Roche	Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
US20060258986A1 (en) *	2005-02-11	2006-11-16	Hunter Ian W	Controlled needle-free transport
PE20070182A1 (es) *	2005-07-29	2007-03-06	Wyeth Corp	Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) *	2005-07-29	2007-04-13	Wyeth Corp	Derivados de pirrol como moduladores del receptor de progesterona
GB0519294D0 (en) *	2005-09-21	2005-11-02	Karobio Ab	Compounds
WO2008063888A2 (fr)	2006-11-22	2008-05-29	Plexxikon, Inc.	Composés modulant l'activité de c-fms et/ou de c-kit et utilisations associées
JP2010533729A (ja)	2007-07-17	2010-10-28	プレキシコン，インコーポレーテッド	キナーゼ調節のための化合物と方法、及びそのための適応
MX2010007929A (es) *	2008-02-04	2010-08-09	Hoffmann La Roche	Imidazolinilmetil aril sulfonamidas novedosas.
CA2711724A1 (fr) *	2008-02-04	2009-08-13	F. Hoffmann-La Roche Ag	Nouveaux imidazolinylmethylarylsulfonamides
JP4168086B1 (ja) *	2008-04-16	2008-10-22	国立大学法人福井大学	イミダゾリン誘導体
CA2738573C (fr)	2009-04-03	2013-02-19	F. Hoffmann-La Roche Ag	Compositions et utilisations associees
US8329724B2 (en)	2009-08-03	2012-12-11	Hoffmann-La Roche Inc.	Process for the manufacture of pharmaceutically active compounds
JP2013510166A (ja)	2009-11-06	2013-03-21	プレキシコンインコーポレーテッド	キナーゼ調節のための化合物、方法およびその適用
PE20141360A1 (es)	2011-02-07	2014-10-13	Plexxikon Inc	Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
TWI558702B (zh)	2011-02-21	2016-11-21	普雷辛肯公司	醫藥活性物質的固態形式
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
TW201603707A (zh) *	2014-06-24	2016-02-01	陶氏農業科學公司	具有特定殺蟲效用之分子及與其相關之中間物、組成物和製程
CN106543077B (zh) *	2016-10-27	2019-08-23	西安交通大学	N,n’-双取代芳基硫脲衍生物及其合成方法和应用
CN106905181B (zh) *	2017-04-14	2018-10-09	上海海洋大学	一种立达霉代谢产物16的合成方法
CN108863818A (zh) *	2018-06-28	2018-11-23	江苏新瑞药业有限公司	一种对氨基间甲酚的合成方法
CN109651289B (zh) *	2018-12-18	2022-08-09	五邑大学	一种3-噻唑啉化合物及其合成方法和应用
EP3958851B1 (fr) *	2019-04-23	2024-08-14	The Cleveland Clinic Foundation	Activateurs allostériques ia du récepteur alpha-adrénergique
US20220401415A1 (en) *	2019-10-25	2022-12-22	Curasen Therapeutics, Inc.	Methods for treating neurological disorders with alpha1a-ar partial agonists
KR20230058066A (ko) *	2020-08-27	2023-05-02	큐라센 테라퓨틱스, 인코포레이티드	α1A-아드레날린성 수용체 작용제 및 사용 방법
WO2024166131A1 (fr)	2023-02-09	2024-08-15	Satyarx Pharma Innovations Private Limited	Composés hétéroaryle en tant qu'inhibiteurs de pkmyt1
CN117447364A (zh) *	2023-10-17	2024-01-26	长沙贝塔医药科技有限公司	一种同位素标记合成对溴氰甲基苯磺酸酯-13c的方法及应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE135016C (fr) *
US2663732A (en) *	1950-04-29	1953-12-22	Eastman Kodak Co	(alkysulfonamido) arylhydrazines
DE1151331B (de) *	1957-11-15	1963-07-11	Bayer Ag	Verfahren zur Herstellung metallhaltiger Monoazofarbstoffe
AT241435B (de) *	1963-06-11	1965-07-26	Chemie Linz Ag	Verfahren zur Herstellung von neuen Phenylalkanolaminderivaten und deren Salzen
ES323985A1 (es) *	1966-02-26	1966-12-16	Blade Pique Juan	Procedimiento para la obtenciën de derivados del imidazol
GB1592649A (en) *	1976-12-20	1981-07-08	Wellcome Found	Imidazoline derivatives and their use as pesticides
DE2756638A1 (de) *	1976-12-20	1978-06-22	Wellcome Found	Imidazoline, verfahren zu ihrer herstellung und ihre verwendung in schaedlingsbekaempfungsmitteln
CH632268A5 (de) *	1977-01-14	1982-09-30	Sandoz Ag	Verfahren zur herstellung von neuen heterocyclylaminoderivaten.
JPS5484575A (en) *	1977-10-26	1979-07-05	Wellcome Found	Imidazoline compound*its manufacture and insecticide composition
ZA801680B (en) *	1979-04-03	1981-03-25	Fujisawa Pharmaceutical Co	2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same
US4343808A (en) *	1979-10-25	1982-08-10	The Dow Chemical Company	Method of inhibiting sickling of sickle erythrocytes
EP0043659B1 (fr) *	1980-07-09	1985-02-06	Beecham Group Plc	Dérivés de clonidine utilisables pour le traitement de la diarrhée
FR2521140A1 (fr) *	1982-02-05	1983-08-12	Synthelabo	Derives d'imidazolidine, leur preparation et leur application en therapeutique
FR2549049B1 (fr) *	1983-07-13	1986-06-20	Chauvin Blache Lab	Nouvelles amidines, leur procede de preparation et leur application therapeutique
HU192986B (en) *	1984-05-23	1987-08-28	Egyt Gyogyszervegyeszeti Gyar	Process for production of imidasodiline derivatives
US4665095A (en) *	1985-12-11	1987-05-12	Abbott Laboratories	Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion
US4956388A (en) *	1986-12-22	1990-09-11	Eli Lilly And Company	3-aryloxy-3-substituted propanamines
DE3842798A1 (de) *	1988-12-20	1990-06-21	Hoechst Ag	Imidazolinderivate enthaltende mittel zur wirtstiersystemischen bekaempfung von ektoparasiten sowie neue imidazolinderivate
PT95899A (pt) *	1989-11-17	1991-09-13	Glaxo Group Ltd	Processo para a preparacao de derivados indole
US5360822A (en) *	1990-02-07	1994-11-01	Nippon Shinyaku Co. Ltd.	Sulfonanilide derivatives and medicine
RU2032671C1 (ru) *	1990-06-29	1995-04-10	Сумитомо Кемикал Компани Лимитед	Производные 1-фенилимидазола, проявляющие инсектицидные свойства, и инсектицидная композиция
US5389650A (en) *	1991-09-30	1995-02-14	Merck Frosst Canada, Inc.	(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
CA2129429A1 (fr) *	1992-02-13	1993-08-14	Richard Frenette	(azaaromaticalkoxy) indoles utilises comme inhibiteurs de la biosynthese de la leucotriene
CA2145182C (fr) *	1992-09-25	2001-09-18	Jonathan A. Bard	Sequences d'adn codant pour des recepteurs alpha 1 adrenergiques humains et leur utilisation
WO1994008040A1 (fr) *	1992-09-25	1994-04-14	Synaptic Pharmaceutical Corporation	Adn codant des recepteurs adrenergiques alpha 1 humains et leurs utilisations
US5403847A (en) *	1992-11-13	1995-04-04	Synaptic Pharmaceutical Corporation	Use of α1C specific compounds to treat benign prostatic hyperlasia
US5578611A (en) *	1992-11-13	1996-11-26	Synaptic Pharmaceutical Corporation	Use of α-1C specific compounds to treat benign prostatic hyperplasia
NZ276883A (en) *	1993-11-15	1998-08-26	Schering Corp	1h-imidazol-4-yl)alkyl]benzene derivatives
US5478858A (en) *	1993-12-17	1995-12-26	The Procter & Gamble Company	5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
US5576437A (en) *	1993-12-17	1996-11-19	The Procter & Gamble Company	7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
AU704972B2 (en) *	1994-08-04	1999-05-13	H. Lundbeck A/S	Novel benzimidazole derivatives
WO1996017612A1 (fr) *	1994-12-08	1996-06-13	Knoll Aktiengesellschaft	Utilisation de composes de phenylamidine et de phenylguanidine substitues dans le traitement de l'ischemie cerebrale et cardiaque, des convulsions et de la drepanocytose
US5597823A (en) *	1995-01-27	1997-01-28	Abbott Laboratories	Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
DE19514579A1 (de) *	1995-04-20	1996-10-24	Boehringer Ingelheim Kg	Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
CA2222573A1 (fr) *	1995-06-02	1996-12-05	Carlos C. Forray	Utilisation d'agents agonistes du recepteur adrenergique alpha-1c-selectif dans le traitement de l'incontinence urinaire
US5610174A (en) *	1995-06-02	1997-03-11	Synaptic Pharmaceutical Corporation	Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence
US5677321A (en) *	1996-02-29	1997-10-14	Synaptic Pharmaceutical Corporation	5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
WO1997042956A1 (fr) *	1996-05-16	1997-11-20	Synaptic Pharmaceutical Corporation	Dihydropyrimidines et leurs emplois

1998
- 1998-05-18 SG SG1998001348A patent/SG72827A1/en unknown
- 1998-05-25 NZ NZ330506A patent/NZ330506A/xx unknown
- 1998-06-03 US US09/089,779 patent/US5952362A/en not_active Expired - Lifetime
- 1998-06-05 CA CA002430623A patent/CA2430623A1/fr not_active Abandoned
- 1998-06-05 CA CA002240136A patent/CA2240136C/fr not_active Expired - Fee Related
- 1998-06-05 CA CA002418778A patent/CA2418778C/fr not_active Expired - Fee Related
- 1998-06-10 IL IL12483998A patent/IL124839A/en not_active IP Right Cessation
- 1998-06-12 ES ES98110822T patent/ES2297870T3/es not_active Expired - Lifetime
- 1998-06-12 AT AT98110822T patent/ATE380793T1/de active
- 1998-06-12 EP EP98110822A patent/EP0887346B1/fr not_active Expired - Lifetime
- 1998-06-12 ID IDP980873A patent/ID20463A/id unknown
- 1998-06-12 DE DE69838829T patent/DE69838829T2/de not_active Expired - Lifetime
- 1998-06-17 HU HU9801357A patent/HUP9801357A3/hu unknown
- 1998-06-18 YU YU26498A patent/YU26498A/sh unknown
- 1998-06-19 JP JP10172403A patent/JP2977536B2/ja not_active Expired - Fee Related
- 1998-06-19 UY UY25057A patent/UY25057A1/es unknown
- 1998-06-19 MY MYPI98002785A patent/MY128048A/en unknown
- 1998-06-19 AR ARP980102929A patent/AR013005A1/es not_active Application Discontinuation
- 1998-06-19 CO CO98035130A patent/CO4940479A1/es unknown
- 1998-06-19 NO NO19982884A patent/NO310868B1/no not_active IP Right Cessation
- 1998-06-22 AU AU73102/98A patent/AU713068C/en not_active Ceased
- 1998-06-22 PE PE1998000547A patent/PE85999A1/es not_active Application Discontinuation
- 1998-06-22 MA MA25130A patent/MA26515A1/fr unknown
- 1998-06-22 RU RU98111769/04A patent/RU2218335C2/ru not_active IP Right Cessation
- 1998-06-22 CN CNB981152090A patent/CN1176910C/zh not_active Expired - Fee Related
- 1998-06-22 CZ CZ981974A patent/CZ197498A3/cs unknown
- 1998-06-22 PL PL326959A patent/PL198053B1/pl not_active IP Right Cessation
- 1998-06-22 CN CNA031264069A patent/CN1515559A/zh active Pending
- 1998-06-22 CN CNB031386059A patent/CN1262547C/zh not_active Expired - Fee Related
- 1998-06-22 KR KR1019980023417A patent/KR100608501B1/ko not_active Expired - Fee Related
- 1998-06-23 HR HR60/075,978A patent/HRP980353A2/hr not_active Application Discontinuation
- 1998-06-23 TW TW087110098A patent/TW517049B/zh not_active IP Right Cessation
- 1998-06-23 BR BRPI9802201-6A patent/BR9802201B1/pt not_active IP Right Cessation
- 1998-06-23 TR TR1998/01197A patent/TR199801197A3/tr unknown
1999
- 1999-03-08 US US09/264,467 patent/US6057349A/en not_active Expired - Fee Related
2003
- 2003-09-04 IL IL15774503A patent/IL157745A0/xx unknown

Also Published As

Publication number	Publication date
CN1515559A (zh)	2004-07-28
HUP9801357A2 (hu)	1999-09-28
EP0887346B1 (fr)	2007-12-12
BR9802201A (pt)	1999-05-25
CA2240136A1 (fr)	1998-12-23
HU9801357D0 (en)	1998-08-28
CO4940479A1 (es)	2000-07-24
AU7310298A (en)	1998-12-24
IL157745A0 (en)	2004-03-28
NZ330506A (en)	1999-10-28
ES2297870T3 (es)	2008-05-01
DE69838829T2 (de)	2008-12-24
CA2418778C (fr)	2006-10-10
NO982884L (no)	1998-12-28
US5952362A (en)	1999-09-14
CZ197498A3 (cs)	1999-01-13
TR199801197A2 (xx)	1999-01-18
PE85999A1 (es)	1999-10-05
KR19990007204A (ko)	1999-01-25
HRP980353A2 (en)	1999-04-30
JP2977536B2 (ja)	1999-11-15
JPH1171353A (ja)	1999-03-16
TR199801197A3 (tr)	1999-01-18
ATE380793T1 (de)	2007-12-15
IL124839A (en)	2004-03-28
AR013005A1 (es)	2000-11-22
TW517049B (en)	2003-01-11
PL326959A1 (en)	1999-01-04
NO982884D0 (no)	1998-06-19
UY25057A1 (es)	2001-01-31
CA2418778A1 (fr)	1998-12-23
CA2430623A1 (fr)	1998-12-23
ID20463A (id)	1998-12-24
YU26498A (sh)	2002-03-18
AU713068C (en)	2004-03-11
EP0887346A3 (fr)	1999-05-06
NO310868B1 (no)	2001-09-10
US6057349A (en)	2000-05-02
EP0887346A2 (fr)	1998-12-30
CN1262547C (zh)	2006-07-05
RU2218335C2 (ru)	2003-12-10
BR9802201B1 (pt)	2009-12-01
HUP9801357A3 (en)	2000-11-28
CN1515562A (zh)	2004-07-28
KR100608501B1 (ko)	2006-12-19
SG72827A1 (en)	2000-05-23
PL198053B1 (pl)	2008-05-30
CN1203228A (zh)	1998-12-30
CN1176910C (zh)	2004-11-24
HK1016985A1 (en)	1999-11-12
DE69838829D1 (de)	2008-01-24
MY128048A (en)	2007-01-31
AU713068B2 (en)	1999-11-25
IL124839A0 (en)	1999-01-26
CA2240136C (fr)	2003-10-21

Publication	Publication Date	Title
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26415A1 (fr)	2004-12-20	Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26536A1 (fr)	2004-12-20	Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26508A1 (fr)	2004-12-20	Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2729951B1 (fr)	1997-04-18	Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2665898B1 (fr)	1994-03-11	Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26571A1 (fr)	2004-12-20	Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA25493A1 (fr)	2002-07-01	Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26439A1 (fr)	2004-12-20	Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24832A1 (fr)	1999-12-31	Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydropyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
MA26420A1 (fr)	2004-12-20	Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
MA24158A1 (fr)	1997-12-31	Derives d'imidazole substitues, procede pour leur preparation et compositions les contenant
MA24242A1 (fr)	1998-07-01	Procede pour la preparation de nouveaux composes